Drug maker Krka sees group net profit rise 26% in Q3
Novo Mesto, 17 November - Pharma company Krka posted a record net profit of just under EUR 302 million for January-September, an increase of 26% over the year before, as revenue rose by 6% to EUR 1.24 billion, also a new record, according to the interim report released on Thursday.
Novo mesto
Production complex of pharmaceutical company Krka
Photo: Tamino Petelinšek/STA
The rest of this news item is available to subscribers.
The news item consists of 1.344 characters (without spaces) or 265 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.